GliosarcomaSymptoms, Doctors, Treatments, Advances & More
Gliosarcoma Overview
Learn About Gliosarcoma
View Main Condition: Brain Tumor
Johns Hopkins Outpatient Center
Henry Brem is a Neurosurgery provider practicing medicine in Baltimore, Maryland. Dr. Brem is rated as an Elite provider by MediFind in the treatment of Gliosarcoma. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Gliosarcoma, Glioma, Gliomatosis Cerebri, Osteotomy, and Posterior Fossa Decompression. Dr. Brem is board certified in American Board Of Neurological Surgery.
Dana-Farber Cancer Institute, Center For Neuro-Oncology
Patrick Wen is a Neurologist practicing medicine in Boston, Massachusetts. Dr. Wen is rated as an Elite provider by MediFind in the treatment of Gliosarcoma. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, and Brain Tumor. Dr. Wen is board certified in Neurology and Neuro-Oncology.
Egil And Pauline Braathen Center/Maroone Cancer Center
Surabhi Ranjan is a Neurologist practicing medicine in Weston, Florida. Dr. Ranjan is rated as an Elite provider by MediFind in the treatment of Gliosarcoma. She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses Gliosarcoma, Metastatic Brain Tumor, Brain Tumor, and Glioma. Dr. Ranjan is board certified in American Board Of Psychiatry And Neurology, 2015.
Summary: This phase I/II trial tests the safety and side effects of atezolizumab in combination with cabozantinib and whether they work to shrink tumors in patients with glioblastoma that has come back (recurrent). Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Cabozan...
Summary: The researchers are doing this study to find out whether the drugs ABBV-637 and ABBV-155 are safe treatments that cause few or mild side effects when given alone or in combination with ERAS-801 in people with recurrent GBM.

Keep Punching supports patients, healthcare providers, and researchers in their fight to prevent and eradicate brain cancer and minimize treatment-related side effects that may adversely impact function and comfort.


